About DeepMeds
Transforming medical imaging with AI for safer, cost-effective exams.
Our Mission
We founded DeepMeds to address the growing concerns around gadolinium retention while maintaining diagnostic confidence in contrast-enhanced MRI. Our AI solutions reduce contrast agent requirements by 80%, improving patient safety without compromising image quality.
Patient Safety First
Reducing gadolinium exposure while maintaining diagnostic confidence
Cost-Effective Care
Substantial contrast agent cost savings at scale
Leadership Team
Dr. Sarah Chen
CEO & Co-Founder
Former MIT CSAIL, PhD in Medical AI
Dr. Raj Patel
CTO & Co-Founder
Ex-Google Brain, ML infrastructure
Dr. Elena Rodriguez
Chief Medical Officer
Neuroradiologist, Harvard Med
Clinical Advisory Board
Dr. Michael Abrams
Professor of Radiology, UCSF
Specialty: Neuro-oncology imaging
Dr. Priya Kapoor
Director of MRI, Mayo Clinic
Specialty: Safety & protocol optimization
Locations
Headquarters
Boston, MA
International
São Paulo | Sydney | London